Expert Ratings for Abbott Laboratories
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 4 analysts have published their opinion on Abbott Laboratories (NYSE:ABT) stock. The majority of these analysts are somewhat bullish on the stock, with an average price target of $116.25, representing a 6.63% decrease from the previous average price target of $124.50.
October 19, 2023 | 4:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Analysts are somewhat bullish on Abbott Laboratories, with an average price target of $116.25, a decrease from the previous target.
The analysts' somewhat bullish stance on Abbott Laboratories indicates a positive outlook for the company. However, the decrease in the average price target suggests that they expect the stock price to decrease in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100